Keywords: biogen, idec, amevive, oked, australia, biotechnology, firm

Biogen Idec's Amevive OKed in Australia

Article | 28 June 2004

Print This

US biotechnology firm Biogen Idec says that the Therapeutic Goods Administration has approved its Amevive (alefacept) for sale in Australia. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in